#United States #Lufax #New York #LLC #Faruqi & Faruqi

Important Reminder for Lufax Investors

As the May 20, 2026 deadline approaches, it’s crucial for investors in Lufax Holding Ltd. to take action regarding a federal securities class action lawsuit. Spearheaded by the national law firm Faruqi & Faruqi, LLP, this investigation comes in response to serious allegations about the company’s financial disclosures and internal controls.

Background on the Allegations

Faruqi & Faruqi, a well-respected name in securities law, emphasizes that potential claims against Lufax relate to breaches of federal securities laws. According to their investigations, the company made false or misleading statements about several critical aspects of its business operations:

1. Inadequate Internal Controls: It was noted that Lufax did not have adequate internal controls in place to ensure accurate financial reporting.
2. Misstatement of Financial Results: Certain financial results were reported in a misleading manner, which could have shaped investors' opinions and decisions based on incorrect data.
3. Impact on Business Statements: Statements provided by Lufax regarding its overall business health were claimed to be materially false and lacked a reasonable basis at all times.

These issues came to light when Lufax disclosed in January 2025 that its board had proposed the removal of its auditors, raising red flags about its financial integrity. Subsequently, the company's stock plummeted by approximately 13.8%, reflecting the immediate impact on investor trust and market confidence.

The Role of Lead Plaintiff

In these lawsuits, a lead plaintiff is appointed to represent the interests of all class members. This individual usually has the largest financial stake in the case and is deemed typical and adequate for overseeing the litigation. Investors who have acquired Lufax securities during the class period (between April 7, 2023, and January 26, 2025) are encouraged to evaluate their options regarding joining the lead plaintiff role or simply remaining class members.

Take Action Now

If you are among the affected shareholders, it is recommended to contact Josh Wilson, Senior Partner at Faruqi & Faruqi, directly at 877-247-4292 or 212-983-9330. Additionally, shareholders who might have information regarding Lufax's practices are encouraged to reach out to the firm. This includes former employees, whistleblowers, and any individuals who can shed light on the situation.

The firm has a rich history of successfully recovering millions for investors and is well-equipped to handle such complex litigation.

Conclusion

As the deadline for claims approaches, Lufax investors must remain vigilant and proactive. With the allegations of inaccuracies in financial reporting and serious internal issues being at play, now is the time to assess your legal rights and make crucial decisions for possible restitution. Keep abreast of developments by visiting Faruqi & Faruqi’s website for comprehensive information and updates.

Legal Disclaimer

This communication may serve as attorney advertising. Past results do not guarantee similar outcomes in future cases. All inquiries will be treated confidentially.